The theme of this 13th edition of the Review, launched in December 2008, is Primary Health Care in South Africa: A review of 30 years since Alma Ata. The SAHR 2008 chapters focus on critical issues in Primary Health Care. The Review includes a national and international perspective of Primary Health Care, and focuses on areas such as policy and legislation, determinants of health, lifestyle, infectious diseases, mental health, maternal and child health, nutrition and environmental health. The SAHR reviews issues around human resources, finance, and information. It also looks at research on health systems, the role of the private and non-governmental organisations in Primary Health Care, and ends with the relevant health and related indicators chapter.
Full SAHR 2008 [pdf 10.5MB]
Primary Health Care: In Context
1 International Perspective on Primary Health Care Over the Past 30 Years [pdf 599Kb]
2 A Perspective on Primary Health Care in South Africa [pdf 570Kb]
3 Health Legislation and Policy [pdf 616Kb]
4 Determinants of Health and their Trends [pdf 311Kb]
Primary Health Care: Programme Areas
5 Chronic Non-Communicable Diseases [pdf 637Kb]
6 STIs, HIV and AIDS and TB: Progress and Challenges [pdf 624Kb]
7 Community Access to Mental Health Services: Lessons and Recommendations [pdf 541Kb]
8 Maternal, Newborn and Child Health: 30 Years On [pdf 595Kb]
9 Nutrition: A Primary Health Care Perspective [pdf 668Kb]
10 Developments in Environmental Health [pdf 1.32Mb]
Primary Health Care: Systems Support
11 Strengthening Human Resources for Primary Health Care [pdf 676Kb]
12 Primary Health Care Financing in the Public Sector [pdf 614Kb]
13 Information for Primary Health Care [pdf 629Kb]
14 A Review of Health Research in South Africa from 1994 to 2007 [pdf 600Kb]
15 The Role of Private and Other Non-Governmental Organisations in Primary Health Care [pdf 590Kb]
16 Health and Related Indicators [pdf 5.88Mb]
A fresh round of funding cuts from rich nations in the wake of the global financial crisis threaten the development of a new generation of lifesaving medicines and vaccines just as they are on the verge of reaching patients in the developing world. Public funding from the world’s richest nations for research and development (R&D) of new neglected disease products fell by US$125m (down 6%) in 2010, according to new data published in the fourth annual G-FINDER report.
It is a year to the day since the World Health Organization (WHO) published its fi rst report on neglected tropical diseases. Almost always out of sight and rarely in news headlines, neglected tropical diseases are found exclusively among poor populations in deprived rural communities. They cause misery and disability, sometimes life-long, to hundreds of millions of people worldwide.